Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Nektar Therapeutics

Start price
Target price
Perf. (%)
€4.42
19.04.22
-
19.04.23
-2.94%
02.05.22

Could be worthwhile Investment >10% per year
buy
Agios Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€25.74
20.02.22
€30.00
20.03.22
2.76%
21.03.22

Could be worthwhile Investment >10% per year
Novocure Ltd

Start price
Target price
Perf. (%)
€59.26
09.01.22
€51.00
09.01.23
8.34%
16.03.22

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
buy
Bluebird Bio Inc.

Start price
Target price
Perf. (%)
€6.22
06.02.22
-
06.02.23
-15.28%
20.02.22

Risky Investment
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€143.65
27.12.21
-
27.12.22
-9.78%
09.01.22

Risky Investment
Arena Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€81.50
13.12.21
-
13.12.22
1.23%
06.01.22

Probably not worthwhile Investment
buy
Sage Therapeutics Inc.

Start price
Target price
Perf. (%)
€47.92
19.06.21
€58.00
19.06.22
-20.72%
27.12.21

Could be worthwhile Investment >10% per year
buy
Ionis Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€37.79
13.12.20
-
13.12.21
-29.55%
14.12.21

Risky Investment
buy
Bio-Techne Corp.

Start price
Target price
Perf. (%)
€13.38
01.11.20
-
04.11.21
100.00%
05.11.21

Could be very worthwhile Investment >20% year
buy
Medpace Holdings Inc

Start price
Target price
Perf. (%)
€91.00
24.09.20
€145.00
04.11.21
114.29%
05.11.21

Could be worthwhile Investment >10% per year
buy
Immunomedics Inc.

Start price
Target price
Perf. (%)
€72.02
19.09.20
-
04.11.21
3.10%
05.11.21

Could be worthwhile Investment >10% per year
buy
Repligen Corp.

Start price
Target price
Perf. (%)
€87.50
12.01.20
€155.00
04.11.21
170.06%
05.11.21

Could be worthwhile Investment >10% per year
buy
Myokardia Inc

Start price
Target price
Perf. (%)
€48.80
13.11.19
€202.00
04.11.21
291.39%
05.11.21

buy
Acadia Healthcare

Start price
Target price
Perf. (%)
€29.22
27.04.19
€39.69
04.11.21
83.06%
05.11.21

buy
Opko Health Inc.

Start price
Target price
Perf. (%)
€2.30
03.04.19
€2.53
04.11.21
59.94%
05.11.21

buy
Immunomedics Inc.

Start price
Target price
Perf. (%)
€17.42
31.03.19
€22.55
04.11.21
326.29%
05.11.21

buy
Acceleron Pharma Inc.

Start price
Target price
Perf. (%)
€42.31
05.03.19
€120.00
04.11.21
254.54%
05.11.21

buy
Tesaro Inc.

Start price
Target price
Perf. (%)
€107.71
23.08.17
€162.36
04.11.21
0.00%
05.11.21

buy
Amicus Therapeutics Inc.

Start price
Target price
Perf. (%)
€11.88
19.08.18
€23.00
04.11.21
-10.77%
05.11.21

buy
Exelixis Inc.

Start price
Target price
Perf. (%)
€25.22
19.01.18
€27.00
04.11.21
-33.98%
05.11.21

buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€112.52
19.01.18
€140.00
04.11.21
42.01%
05.11.21

Alnylam Pharmace.

Start price
Target price
Perf. (%)
€180.85
16.10.21
€160.00
16.10.22
-6.22%
24.10.21

Could be worthwhile Investment >10% per year
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€109.44
27.11.19
-
04.11.21
65.25%
16.10.21

Could be worthwhile Investment >10% per year
buy
Acceleron Pharma Inc.

Start price
Target price
Perf. (%)
€133.00
22.09.21
€200.00
31.12.23
18.80%
28.09.21

Could be very worthwhile Investment >20% year
buy
Sage Therapeutics Inc.

Start price
Target price
Perf. (%)
€38.22
13.08.21
-
13.08.22
-3.95%
22.08.21

Risky Investment